Roche Ramps Up Breast Cancer Pipeline With Regor’s CDK Inhibitors
Roche RHHBY announced an asset purchase agreement with clinical-stage biotechnology company Regor Therapeutics. Per the agreement, Roche’s Genentech…
Browsing Tag